Anaesthesia application modes compared

Article

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Contact anaesthesia is just as safe and effective as peribulbar application for combined cataract and glaucoma surgery, according to study results published online ahead of print by Ophthalmologica.

Luis E. Pablo of the Department of Ophthalmology at Miguel Servet University Hospital, Zaragoza, Spain and colleagues conducted a randomized study of patients undergoing phacotrabeculectomy (n=120), assessing pain, complications and success of surgery and comparing the results obtained by patients receiving topical contact anaesthesia with those obtained from peribulbar anaesthesia injection.

The team found that peribulbar injection was associated with more pain than topical anaesthesia at the time of application; during and after surgery, however, there was no difference in the levels of pain experienced by the separate groups. In terms of both tension and visual acuity, there was again no difference between the groups treated with the different application methods.

Therefore the researchers concluded that, during surgery and in the mid- to long-term, topical anaesthesia application and peribulbar application are associated with similar outcomes and levels of pain.

Recent Videos
(Image credit: Ophthalmology Times Europe) AGS 2025: Clemens Strohmaier, PhD, on improving aqueous humour outflow following excimer laser trabeculostomy
Anat Loewenstein, MD, speaks about the 22nd Annual Angiogenesis, Exudation, and Degeneration Meeting in February 2025 and shares her global forecast for AI-driven home OCT
Sarah M. Thomasy, DVM, PhD, DACVO, a veterinary ophthalmologist at UC Davis, talks about how her research at the Glaucoma 360 symposium
I. Paul Singh, MD, an anterior segment and glaucoma specialist, discusses the Glaucoma 360 conference, where he participated in a panel discussion on the use of artificial intelligence (AI) in glaucoma care.
Charles Wykoff, MD, PhD, discusses his Floretina ICOOR presentation topic, retinal non-perfusion in diabetic retinopathy, with David Hutton, editor of Ophthalmology Times
Elizabeth Cohen, MD, discusses the Zoster Eye Disease study at the 2024 AAO meeting
Vikas Chopra at AAO 2024: Advancements in MIGS are transforming patient care
Victoria L Tseng, MD, PhD, professor of ophthalmology and glaucoma specialist, UCLA
© 2025 MJH Life Sciences

All rights reserved.